Precigen, Inc. (PGEN)

NASDAQ: PGEN · Real-Time Price · USD

3.830

+0.020 (0.52%)

Feb 27, 2026, 9:38 AM EST - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Exemplar	3.93M	6.15M	12.02M	13.35M	10.16M
Exemplar Growth	-36.18%	-48.81%	-9.97%	31.37%	45.84%
Biopharmaceuticals	-	75.00K	14.89M	922.00K	26.58M
Biopharmaceuticals Growth	-	-99.50%	1515.40%	-96.53%	38.66%
Eliminations	-	-	-	-	-4.80M
Unallocated Other Revenues	-	-	-	-	54.00K
Unallocated Other Revenues Growth	-	-	-	-	-99.40%
Total	3.93M	6.23M	26.91M	14.27M	31.99M
Total Growth	-36.95%	-76.87%	88.61%	-55.40%	-66.61%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States of America	3.93M	6.23M	26.68M	13.89M	31.40M
United States of America Growth	-36.95%	-76.66%	92.07%	-55.76%	-64.85%
Foreign Countries	-	-	233.00K	378.00K	595.00K
Foreign Countries Growth	-	-	-38.36%	-36.47%	-57.53%
Total	3.93M	6.23M	26.91M	14.27M	31.99M
Total Growth	-36.95%	-76.87%	88.61%	-55.40%	-64.74%

Source: S&P Global Market Intelligence.